148 related articles for article (PubMed ID: 17100859)
1. Quantifying the impact of survivor treatment bias in observational studies.
Austin PC; Mamdani MM; van Walraven C; Tu JV
J Eval Clin Pract; 2006 Dec; 12(6):601-12. PubMed ID: 17100859
[TBL] [Abstract][Full Text] [Related]
2. Survivor treatment selection bias and outcomes research: a case study of surgery in infective endocarditis.
Sy RW; Bannon PG; Bayfield MS; Brown C; Kritharides L
Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):469-74. PubMed ID: 20031879
[TBL] [Abstract][Full Text] [Related]
3. Bayesian propensity score analysis for observational data.
McCandless LC; Gustafson P; Austin PC
Stat Med; 2009 Jan; 28(1):94-112. PubMed ID: 19012268
[TBL] [Abstract][Full Text] [Related]
4. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods.
Zhou Z; Rahme E; Abrahamowicz M; Pilote L
Am J Epidemiol; 2005 Nov; 162(10):1016-23. PubMed ID: 16192344
[TBL] [Abstract][Full Text] [Related]
5. Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias.
Tleyjeh IM; Ghomrawi HM; Steckelberg JM; Montori VM; Hoskin TL; Enders F; Huskins WC; Mookadam F; Wilson WR; Zimmerman V; Baddour LM
J Clin Epidemiol; 2010 Feb; 63(2):130-5. PubMed ID: 20122499
[TBL] [Abstract][Full Text] [Related]
6. Use of time-dependent measures to estimate benefits of beta-blockers after myocardial infarction.
Levy AR; Tamblyn RM; Abrahamowicz M; McLeod PJ; Fitchett D
Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):623-31. PubMed ID: 15362086
[TBL] [Abstract][Full Text] [Related]
7. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis.
Tleyjeh IM; Ghomrawi HM; Steckelberg JM; Hoskin TL; Mirzoyev Z; Anavekar NS; Enders F; Moustafa S; Mookadam F; Huskins WC; Wilson WR; Baddour LM
Circulation; 2007 Apr; 115(13):1721-8. PubMed ID: 17372170
[TBL] [Abstract][Full Text] [Related]
8. Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.
Hirsch A; Windhausen F; Tijssen JG; Oude Ophuis AJ; van der Giessen WJ; van der Zee PM; Cornel JH; Verheugt FW; de Winter RJ;
Eur Heart J; 2009 Mar; 30(6):645-54. PubMed ID: 18824461
[TBL] [Abstract][Full Text] [Related]
9. Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program).
Nagashima M; Koyanagi R; Kasanuki H; Hagiwara N; Yamaguchi J; Atsuchi N; Honda T; Haze K; Sumiyoshi T; Urashima M; Ogawa H;
Am J Cardiol; 2007 Jun; 99(11):1523-8. PubMed ID: 17531574
[TBL] [Abstract][Full Text] [Related]
10. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
11. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
[TBL] [Abstract][Full Text] [Related]
12. Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study.
Holme I; Szarek M; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):315-20. PubMed ID: 19322096
[TBL] [Abstract][Full Text] [Related]
13. Time-related aspects of the healthy worker survivor effect.
Richardson D; Wing S; Steenland K; McKelvey W
Ann Epidemiol; 2004 Oct; 14(9):633-9. PubMed ID: 15380793
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
Pipilis A; Andrikopoulos G; Lekakis J; Kalantzi K; Kitsiou A; Toli K; Floros D; Gaita D; Karalis I; Dragomanovits S; Kalogeropoulos P; Synetos A; Koutsogiannis N; Stougiannos P; Antonakoudis C; Goudevenos J;
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):85-90. PubMed ID: 19188809
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of statin therapy on survival in hypertensive patients with acute myocardial infarction: data from the RICO survey.
Sicard P; Zeller M; Dentan G; Laurent Y; Touzery C; L'huillier I; Janin-Manificat L; Lorgis L; Beer JC; Makki H; Rochette L; Cottin Y;
Am J Hypertens; 2007 Nov; 20(11):1133-9. PubMed ID: 17954357
[TBL] [Abstract][Full Text] [Related]
17. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):895-900. PubMed ID: 18936454
[TBL] [Abstract][Full Text] [Related]
18. Reduction in sex-based mortality difference with implementation of new cardiology guidelines.
Novack V; Cutlip DE; Jotkowitz A; Lieberman N; Porath A
Am J Med; 2008 Jul; 121(7):597-603.e1. PubMed ID: 18538296
[TBL] [Abstract][Full Text] [Related]
19. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
[TBL] [Abstract][Full Text] [Related]
20. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
